Forgotten500k - Forgotten Lives UK

02/03/2023

Today marks the release of the APPG for Vulnerable Groups to Pandemics UK Inquiry report into the Forgotten 500k Immunocompromised Patients.

This is one of the most the most significant documents produced to date as it really highlights the the multiple and significant failures by the Government in its handling of the pandemic.

The APPG will be sending this document out to all MP's across the house and also the DHSC. Please help us spread this document far and wide. We need you to share this with your MP's too, Media, Charities, Clinicians and anyone you think needs to know. We need to get it out there.

We also want to take time to a say huge thank you to everyone who was involved in the significant piece of work. We are really grateful.

Please find the link below to the APPG Report.
https://getevusheld.uk/assets/downloads/2023-03-02-APPG-Inquiry-Report.pdf

Below is the press release from the APPG.

https://getevusheld.uk/assets/downloads/2023-03-02-APPG-report-release.pdf

02/11/2022

“I haven’t seen my eldest son since February 2020”

For Carole, Evusheld could help seeing her own son become a reality again. Something so simple but powerful.

You can help people like Carole, one of the

Visit getevusheld.uk/500k today

28/10/2022

On Wednesday, family and friends of the came together for a vigil of support on Parliament Square. We were supported by several MPs and community members all agreeing that should be rolled out on the NHS this winter!

Find out more here: getevusheld.uk/500k

26/10/2022

Today the friends and family of the stood together during a vigil in Parliament Square, to call upon the government to roll out on the NHS ahead of this winter.

Help the get their lives back and getevusheld.uk/500k today

25/10/2022

Great support from our friends at the Mail, for our Forgotten500k campaign.

THE father unable to hug his teenage daughter. The retired nurse too scared to walk down the street to the shops. The 25-year-old transplant patient whose friends no longer call because he hasn’t left the house in nearly three years, and the 70-year-old former teacher who has had no visitors since...

24/10/2022

“If I got Evusheld, I’d immediately move back home and be back together with my daughter and my husband”

Shannon’s life was shattered when covid-19 struck. But Evusheld can help her begin to rebuild it.

You can help people like Shannon, one of the

Visit getevusheld.uk/500k today

24/10/2022

As past of the Mail on Sunday campaign for the Forgotten500k, this podcast is well worth a listen.

https://www.mailplus.co.uk/radio/medical-minefield/231500/why-wont-health-chiefs-approve-the-new-covid-drug-thats-proven-to-save-lives?fbclid=IwAR02VmaPo1vQaEsCk0JcsQZFwYKJolPHR2qnR50EiiqsJip8_SjuY6d5LdM

To enjoy this content please ACCEPT cookies. Cookies are used to analyse traffic which we share with our analytics partners.

23/10/2022

Many of you watched the whole Tortoise media event last week in which Evusheld for the UK co-leader, Mark Oakley, bared his soul and urged people to remember the human tragedies behind the UK government's callous decision not to procure Evusheld.

It was powerful, hard-hitting, and very difficult to watch. We need to get this kind of message in front of politicians, because it's hard for them to see and sit through.

To make this easier, Martin has edited down Mark's story into a much shorter segment on Youtube. The link is here: https://youtu.be/Vs623byoC3c

Do please send it on to anybody who still doesn't get it. To anyone who doesn't understand what restrictions we still face. And particularly to politicians who are hiding behind the numbers, rather than looking the reality in the face.

For 500k people in the UK, the pandemic is still a serious threat. Here, Mark Oakley of Evusheld for the UK describes the ongoing nightmare that the UK gover...

21/10/2022

Yesterday we joined Tortoise Media co-founder and editor James Harding, for a ThinkIn to discuss why Evusheld is being blocked in the same country that makes it.

An enormous thank you to Lord Mendelsohn; Daisy Cooper MP; Dr. Lennard Lee, Academic Clinical Lecturer in Medical Oncology at the University of Oxford; Mark Oakley Evusheld for the UK, and Helen Rowntree, Director of Research, Services and Engagement at Blood Cancer UK, who talked about the huge impact this decision is having on the people who just want their lives back.

Next week we continue our campaign with a vigil in Parliament Square where we will stand together for the , who themselves cannot be there.

You can watch the full ThinkIn here: https://youtu.be/BWpAQe-48vE

21/10/2022

"I’m currently isolating with my family and they gave up their lives for me”

Simply put, Evusheld would help Lesley and her family get their lives back, still on hold from nearly 3 years ago.

You can help people like Lesley, one of the

Visit getevusheld.uk/500k today

20/10/2022

Our campaign for the continues with the host of the Crisis What Crisis? Podcast, Andy Coulson, shedding more light on the crisis being endured by the Forgotten 500,000. These half a million immunocompromised people in the UK need a treatment called Evusheld to protect them against the deadly threat of Covid.

In this special episode, Andy is joined by Dr. Lennard Lee, a leading NHS oncologist who is campaigning with English Professor Martin Eve, to bring an end to this disastrous situation.

Martin shares his experience as an immunocompromised person living in the UK, and how even going to the shop can pose a potential existential threat.

Listen to the podcast here: https://podcast.crisiswhatcrisis.com/forgotten500k

Visit getevusheld.uk/500k today.

19/10/2022

We’d like to invite you to join us, tomorrow, Thursday 20th October, 1-2pm, online, for a special discussion hosted by Tortoise Media about the Government's refusal to make Evusheld available on the NHS!

The link to tune in is here: https://tortoisemedia.zoom.us/j/87035767579

The panel includes Lord Mendelsohn; Daisy Cooper MP; Dr Lennard Lee, Academic Clinical Lecturer in Medical Oncology at the University of Oxford; Mark Oakley, Evusheld for the UK, and Helen Rowntree, Director of Research, Services and Engagement at Blood Cancer UK.